General Announcement::Press Release: iX Biopharma Records 1H22 Net Profit of S$3.66M

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
11-Feb-2022 12:32:19
Status
New
Announcement Sub Title
Press Release: iX Biopharma Records 1H22 Net Profit of S$3.66M
Announcement Reference
SG220211OTHRDFIP
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please see attached.

Attachments

Press Release - iX Biopharma Records 1H22 Net Profit 3.66M final.pdf
Total size =70K